Anti-apoptotic effect of HIV protease inhibitors via direct inhibition of calpain

Biochemical Pharmacology

Volumn 66, Issue 8, 2003, Pages 1505-1512

  Ghibelli, Lina ^a   Mengoni, Fabio ^b   Lichtner, Miriam ^b   Coppola, Simona ^a   De Nicola, Milena ^a   Bergamaschi, Antonio ^c   Mastroianni, Claudio ^b   Vullo, Vincenzo ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Acquired immunodeficiency syndrome; AIDS; D MEM; Death inducing signaling complex; DISC; Dulbecco's modified Eagle's medium; EDTA; EGTA; Ethylenglycolaminoethyltetracetic acid; Etylendiaminetetracetic acid; FCS; Fetal calf serum; HIV; Human immunodeficiency virus

Indexed keywords

CALPAIN; CALPASTATIN; CASPASE; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR;

CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; APOPTOSIS; ARTICLE; DRUG ANTAGONISM; METABOLISM;

APOPTOSIS; CALPAIN; CASPASES; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; RITONAVIR;

EID: 0642345201     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00505-7     Document Type: Conference Paper

References (31)

1. Chen M., Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis. 7:2002;313-319.
2. Chan S.L., Mattson M.P. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58:1999;167-190.
3. Vanderklish P.W., Bahr B.A. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 81:2000;323-339.
4. Spinedi A., Oliverio S., Di Sano F., Piacentini M. Calpain involvement in Calphostin C-induced apoptosis. Biochem. Pharmacol. 56:1998;1489-1492.
5. Badley A.D., Pilon A.A., Landay A., Lynch D.H. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 96:2000;2951-2964.
6. Badley A.D., Parato K., Cameron D.W., Kravcik S., Phenix B.N., Ashby D., Kumar A., Lynch D.H., Tschopp J., Angel J.B. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ. 6:1999;420-432.
7. Flexner C. HIV-protease inhibitors. N. Engl. J. Med. 338:1998;1281-1292.
8. Mezzaroma I., Carlesimo M., Pinter E., Muratori D.S., Di Sora F., Chiarotti F., Cunsolo M.G., Sacco G., Aiuti F. Clinical and immunological response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy. Clin. Infect. Dis. 29:1999;1423-1430.
9. Ledergerber B., Egger M., Opravil M., Telenti A., Hirschel B., Battegay M., Vernazza P., Sudre P., Flepp M., Furrer H., Francioli P., Weber R. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet. 353:1999;863-869.
10. Levitz S.M. Improvement in CD4+ cell counts despite persistently detectable HIV load. N. Engl. J. Med. 338:1998;1074-1075.
11. Kaufmann D. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Lancet. 351:1998;723-724.
12. Mastroianni C.M., Mengoni F., Lichtner M., D'Agostino C., d'Ettorre G., Forcina G., Marzi M., Russo G., Massetti A.P., Vullo V. Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis. J. Infect. Dis. 182:2000;1536-1539.
13. Weichold F.F., Bryant J.L., Pati S., Barabitskaya O., Gallo R.C., Reitz M.S. Jr. HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells. J. Hum. Virol. 2:1999;261-269.
14. Sloand E.M., Kumar P.N., Kim S., Chaudhuri A., Weichold F.F., Young N.S. Human immunodeficiency virus Type 1 protease inhibitor modulates activation of peripheral bllod CD4+ T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood. 94:1999;1021-1027.
15. Komiyama T., Ray C.A., Pickup D.J., Howard A.D., Thornberry N.A., Peterson E.P., Salvesen G. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition G. J. Biol. Chem. 269:1994;19331-19337.
16. Ghibelli L., Coppola S., Fanelli C., Rotilio G., Civitareale P., Scovassi A.I., Ciriolo M.R. Glutathione depletion causes Cytochrome c release even in the absence of cell commitment to apoptosis. FASEB J. 13:1999;2031-2036.
17. Coppola S., Ghibelli L. GSH extrusion and the mitochondrial pathway of apoptotic signaling. Biochem. Soc. Trans. 28:2000;56-61.
18. Rock K.L. Inhibitors of the proteasome block the degradation of the of most cell proteins and the generation of peptidespresented on MHC class I molecules. Cell. 78:1994;761-771.
19. McGinnis K.M., Wang K.K., Gnegy M.E. Alterations of extracellular calcium elicit selective modes of cell death and protease activation in SH-SY5Y human neuroblastoma cells. J. Neurochem. 72:1999;1853-1863.
20. Squier M.K., Cohen J.J. Calpain, an upstream regulator of thymocyte apoptosis. J. Immunol. 158:1997;3690-3697.
21. Vanags D.M., Porn-Ares M.I., Coppola S., Burgess D., Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:1996;31075-31085.
22. Blomgren K., Zhu C., Wang X., Karlsson J.O., Leverin A.L., Bahr B.A., Mallard C., Hagberg H. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J. Biol. Chem. 276:2001;10191-10198.
23. Saido T.C., Sorimachi H., Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8:1994;814-822.
24. Gao G., Dou Q.P. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J. Cell Biochem. 80:2000;53-72.
25. Wan W., DePetrillo P. Ritonavir inhibition of calcium-activated proteases. Biochem. Pharmacol. 63:2002;1481-1484.
26. Piccinini M., Rinaudo M.T., Chiapello N., Ricotti E., Baldovino S., Mostert M., Tovo P.A. The human 26S proteasome is a target of antiretroviral agents. AIDS. 16:2002;693-700.
27. Grimm L.M., Goldberg A.L., Poirier G.G., Schwartz L.M., Osborne B.A. Proteosomes play an essential role in tymocyte apoptosis. EMBO J. 15:1996;3835-3844.
28. Pasquini L.A., Besio Moreno M., Adamo A.M., Pasquini J.M., Soto E.F. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J. Neurosci. Res. 59:2000;601-611.
29. Squier M.K., Sehnert A.J., Sellins K.S., Malkinson A.M., Takano E., Cohen J.J. Calpain and calpastatin regulate neutrophil apoptosis. J. Cell Physiol. 178:1999;311-319.
30. Wang K.W., Po-Wai Y. Calpain inhibition: an overview of its therapeutic potential. Trends Pharmacol. 15:1994;412-419.
31. Nakagawaa T., Yuana J. Cross-talk between two cysteine protease families: activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150:2000;887-894.